Feedback
Settings

Settings

Goto Application

1. WO2003037346 - 6-PHENYL-N-PHENYL-(1,3,5) -TRIAZINE-2,4-DIAMINE DERIVATIVES AND RELATED COMPOUNDS WITH LYSOPHPHOSPHATIDIC ACID ACYLTRANSFERASE BETA (LPAAT-BETA) INHIBITORY ACTIVITY FOR USE IN THE TREATMENT OF CANCER

PermaLink
Publication Number WO/2003/037346
Publication Date 08.05.2003
International Application No. PCT/US2002/035256
International Filing Date 30.10.2002
Chapter 2 Demand Filed 20.05.2003
IPC
C07D 251/16 2006.1
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
251Heterocyclic compounds containing 1,3,5-triazine rings
02not condensed with other rings
12having three double bonds between ring members or between ring members and non-ring members
14with hydrogen or carbon atoms directly attached to at least one ring carbon atom
16to only one ring carbon atom
C07D 251/18 2006.1
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
251Heterocyclic compounds containing 1,3,5-triazine rings
02not condensed with other rings
12having three double bonds between ring members or between ring members and non-ring members
14with hydrogen or carbon atoms directly attached to at least one ring carbon atom
16to only one ring carbon atom
18with nitrogen atoms directly attached to the two other ring carbon atoms, e.g. guanamines
C07D 251/22 2006.1
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
251Heterocyclic compounds containing 1,3,5-triazine rings
02not condensed with other rings
12having three double bonds between ring members or between ring members and non-ring members
14with hydrogen or carbon atoms directly attached to at least one ring carbon atom
22to two ring carbon atoms
C07D 403/12 2006.1
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
403Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/167
02containing two hetero rings
12linked by a chain containing hetero atoms as chain links
C07D 405/12 2006.1
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
405Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
02containing two hetero rings
12linked by a chain containing hetero atoms as chain links
CPC
A61P 35/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
35Antineoplastic agents
C07D 251/16
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
251Heterocyclic compounds containing 1,3,5-triazine rings
02not condensed with other rings
12having three double bonds between ring members or between ring members and non-ring members
14with hydrogen or carbon atoms directly attached to at least one ring carbon atom
16to only one ring carbon atom
C07D 251/18
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
251Heterocyclic compounds containing 1,3,5-triazine rings
02not condensed with other rings
12having three double bonds between ring members or between ring members and non-ring members
14with hydrogen or carbon atoms directly attached to at least one ring carbon atom
16to only one ring carbon atom
18with nitrogen atoms directly attached to the two other ring carbon atoms, e.g. guanamines
C07D 251/22
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
251Heterocyclic compounds containing 1,3,5-triazine rings
02not condensed with other rings
12having three double bonds between ring members or between ring members and non-ring members
14with hydrogen or carbon atoms directly attached to at least one ring carbon atom
22to two ring carbon atoms
C07D 403/12
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
403Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
02containing two hetero rings
12linked by a chain containing hetero atoms as chain links
C07D 405/12
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
405Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
02containing two hetero rings
12linked by a chain containing hetero atoms as chain links
Applicants
  • CELL THERAPEUTICS, INC. [US]/[US] (AllExceptUS)
  • BHATT, Rama [US]/[US] (UsOnly)
  • GONG, Baoqing [US]/[US] (UsOnly)
  • HONG, Feng [CN]/[US] (UsOnly)
  • JENKINS, Scott, A. [US]/[US] (UsOnly)
  • KLEIN, J., Peter [US]/[US] (UsOnly)
  • KUMAR, Anil, M. [IN]/[US] (UsOnly)
  • TULINSKY, John [US]/[US] (UsOnly)
Inventors
  • BHATT, Rama
  • GONG, Baoqing
  • HONG, Feng
  • JENKINS, Scott, A.
  • KLEIN, J., Peter
  • KUMAR, Anil, M.
  • TULINSKY, John
Agents
  • SHARKEY, Richard, G.
Priority Data
60/330,77231.10.2001US
Publication Language English (en)
Filing Language English (EN)
Designated States
Title
(EN) 6-PHENYL-N-PHENYL-(1,3,5) -TRIAZINE-2,4-DIAMINE DERIVATIVES AND RELATED COMPOUNDS WITH LYSOPHPHOSPHATIDIC ACID ACYLTRANSFERASE BETA (LPAAT-BETA) INHIBITORY ACTIVITY FOR USE IN THE TREATMENT OF CANCER
(FR) DERIVES DE 6-PHENYL-N-PHENYL-(1,3,5)-TRIAZINE-2,4-DIAMINE ET COMPOSES APPARENTES AYANT UN EFFET INHIBITEUR DE L'ACIDE LYSOPHOSPHATIDIQUE ACYLTRANSFERASE BETA (LPAAT-BETA) ET DESTINES A ETRE UTILISES POUR TRAITER LE CANCER
front page image
Abstract
(EN) The invention relates to aryl triazines and uses thereof, including to inhibit lysophosphatidic acid acyltransferase $g(b) (LPAAT-$g(b)) activity and/or proliferation of cells such as tumor cells, where R1-R5 are hydrogen or non-ydrogen substituents, and Q is a heteroatom or heteroatom attached to one or more methylene groups.
(FR) La présente invention concerne des aryltriazines de formule (I) et leur utilisation, dont l'inhibition de l'acide lysophosphatidique acyltransférase $g(b) (LPAAT-$g(b)) et / ou de la prolifération de cellules telles que des cellules tumorales. Dans ladite formule, R1 à R5 représentent des substituants hydrogène ou non-hydrogène, et Q représente un hétéroatome ou un hétéroatome attaché à un ou plusieurs groupes méthylène.
Related patent documents
AU2002353991
US20030153570
US20080064700
Latest bibliographic data on file with the International Bureau
# -